Roche’s Vabysmo to offer ‘fierce competition’ to Regeneron’s Eylea
Summary : Roche’s Vabysmo is having a strong start with doctors, but it has a long way to go if it wants…
Summary : Roche’s Vabysmo is having a strong start with doctors, but it has a long way to go if it wants…
Summary: The U.S. Food and Drug Administration (FDA) has revised its emergency use authorization (EUA) for AstraZeneca’s Evusheld to a higher dose…
Summary : The U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for bebtelovimab, an antibody that demonstrates…
Synopsis- Ichnos Sciences, Glenmark’s drug discovery subsidiary based in the US, on Tuesday said it has entered into an exclusive agreement with…
Summary – French health authorities have approved the use of an antibody treatment made by AstraZeneca for high-risk people who show resistance…
Summary : With the FDA’s emergency use authorization today of AstraZeneca’s long-acting antibody cocktail, the roughly 2% of U.S. residents who are…
Synopsis: The FDA’s authorization expands the drug’s use to fight Covid-19 to people under the age of 12 The therapy, Bamlanivimab plus…
Synopsis : SPARC enters agreement with Biomodifying to gain rights on antibody to treat cancer Sun Pharma Advanced Research Company (SPARC) gained…
HIGHLIGHTS: Spain’s top research institution struck a licensing deal that paves the way for its COVID-19 antibody test to be produced more…
SYNOPSIS US government contracts for approximately $1 billion (USD) are now in place to purchase Sotrovimab, further expanding access nationwide Sotrovimab, an…